Paroxysmal Nocturnal Hemoglobinuria (PNH) - Biology, Pathogenesis, Eculizumab trials, Ravulizumab FDA Approval & Next Generation Complement Inhibitors
By
Indy Hematology Review
FEATURING
Robert Brodsky
By
Indy Hematology Review
FEATURING
Robert Brodsky
Comments 0
Login to view comments.
Click here to Login